Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro
- PMID: 1649132
- DOI: 10.1007/BF00917508
Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro
Abstract
Inhibition of prostanoid synthesis is usually regarded as the mode of action of nonsteroidal antiinflammatory drugs (NSAIDs). In addition, some NSAIDs have been reported to have prostanoid-independent inhibitory effects on neutrophil functions. In the present study, we examined the effects of acetylsalicylic acid, diclofenac, indomethacin, ketoprofen, piroxicam and tolfenamic acid on leukotriene B4 (LTB4)-induced chemotaxis of human polymorphonuclear leukocytes (PMNs) in vitro. Tolfenamic acid inhibited LTB4-induced chemotaxis (IC50 59 microM), whereas the other compounds were ineffective. Tolfenamic acid inhibited also FMLP-induced chemotaxis at the same concentration range (IC50 46 microM). About 25% reduction in the chemotactic response was achieved with therapeutic concentrations of tolfenamic acid. We suggest that the inhibition of PMN chemotaxis is an additional mechanism in the antiinflammatory action of tolfenamic acid and that this action is not ligand specific.
Similar articles
-
Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions.Inflammation. 1993 Aug;17(4):417-25. doi: 10.1007/BF00916582. Inflammation. 1993. PMID: 8406686
-
Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec;350(6):685-91. doi: 10.1007/BF00169375. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7708126
-
Tolfenamic acid and leukotriene synthesis inhibition.Pharmacol Toxicol. 1994;75 Suppl 2:60-3. doi: 10.1111/j.1600-0773.1994.tb02000.x. Pharmacol Toxicol. 1994. PMID: 7816785 Review. No abstract available.
-
15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.Skin Pharmacol. 1988;1(2):93-9. doi: 10.1159/000210754. Skin Pharmacol. 1988. PMID: 2856182
-
Arachidonic acid, leukotriene B4, and neutrophil activation.Ann N Y Acad Sci. 1983;414:125-39. doi: 10.1111/j.1749-6632.1983.tb31679.x. Ann N Y Acad Sci. 1983. PMID: 6322649 Review. No abstract available.
Cited by
-
Interactions between synthesis of platelet-activating factor and leukotriene B4 in isolated human polymorphonuclear leukocytes.Inflammation. 1993 Dec;17(6):705-14. doi: 10.1007/BF00920475. Inflammation. 1993. PMID: 8112829
-
Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions.Inflammation. 1993 Aug;17(4):417-25. doi: 10.1007/BF00916582. Inflammation. 1993. PMID: 8406686
-
Tolfenamic Acid Suppresses Inflammatory Stimuli-Mediated Activation of NF-κB Signaling.Biomol Ther (Seoul). 2015 Jan;23(1):39-44. doi: 10.4062/biomolther.2014.088. Epub 2015 Jan 1. Biomol Ther (Seoul). 2015. PMID: 25593642 Free PMC article.
-
Preparation, Characterization and Pharmacokinetics of Tolfenamic Acid-Loaded Solid Lipid Nanoparticles.Pharmaceutics. 2022 Sep 13;14(9):1929. doi: 10.3390/pharmaceutics14091929. Pharmaceutics. 2022. PMID: 36145677 Free PMC article.
-
Effect of norathyriol, isolated from Tripterospermum lanceolatum, on A23187-induced pleurisy and analgesia in mice.Naunyn Schmiedebergs Arch Pharmacol. 1994 Jul;350(1):90-5. doi: 10.1007/BF00180016. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7935860